Ligand Pharmaceuticals Incorporated
Methods and compositions for modulating hormone levels
Last updated:
Abstract:
Provided herein are compositions and methods for the treatment of androgen and estrogen receptors mediated conditions.
Status:
Grant
Type:
Utility
Filling date:
16 Sep 2019
Issue date:
29 Dec 2020